All Posts

Alzheimer's Disease Market Infographic
Alzheimer’s Disease Market Infographic

Alzheimer's Disease Market Infographic It's is the end of Alzheimer's Awareness Month, but our hope for a cure for this disease will not end. They may not remember us, but we need to remember that Alzheimer's battle is not theirs alone, but all of ours.

Find More

UREA CYCLE DISORDER Market
UREA CYCLE DISORDER – A LOST ENZYME may lead to FATAL RISKS

Do you feel sleepy or fussy? Do you suffer from seizures or breathing problem? And your body temperature is mostly low?You should get it checked, as this can be related to any disease or disorder, which can be either fatal or superficial. You might be afflicted with Urea cycle disorder. Delaying it would not bring ...

Find More

Pharma News
Toujeo to treat Type 1 Diabetes; TauRx for Alzheimer’s patients

Sanofi’s Toujeo has received FDA recommendation for its expanded use in Type 1 Diabetes. Toujeo is an insulin glargine injection to control the highs and lows of blood sugar in the body. Indicated to be used in adults and paediatric patients of age six and older. Earlier, the injection was considered suitab...

Find More

Sickle cell disease treatment
Novel treatment approval promises a better future for Sickle cell disease patients

Sickle cell disease is a haematological, genetic disorder that affects millions of people worldwide. According to the NIH, “Sickle cell disease is the most common inherited blood disorder in the United States, affecting 70,000 to 80,000 Americans’’. The estimates are somewhat similar to that of CDC’s according t...

Find More

Pharma News
Novartis buys Medicines; Blackstone Life Sciences and Ferring’s collaboration; Alexion’s Soliris (eculizumab) Approval;

Novartis plans to buy The Medicines Company for USD 9.7 Billion to gain access to a heart drug inclisiran, almost ready to get into the market. Under the terms of the deal, Novartis will pay USD 85 per share to the Medicines Company, a cholesterol drug developer, making the deal up to USD 9.7 Billion. The whole...

Find More

Beta thalassemia market
How Gene therapy is changing the Beta-thalassemia Treatment outlook?

Beta thalassemia, globally affects almost 288,000 people, with an incidence of 60,000 cases every year. A rare monogenic genetic disease, beta-thalassemia is caused by more than 200 mutations of the beta-globin gene (HBB). The Beta-thalassemia pharmacological treatment mainly comprises of regular blood-transfus...

Find More

Biosimilar Market
The long journey of Biosimilars: Is it an emerging opportunity?

Biologics are not new drugs, their use as a medicine has been around for over a century. The first use of Biologic drug dates back to the year 1796 when the vaccine to treat smallpox was created.They have been revolutionizing the treatment approaches for the past many years. Hormones, insulin, blood products, cytok...

Find More

Pharma news
GHO to advance healthcare in Europe; Truvian nets USD 27.1 Mn; Lilly plans its diabetes portfolio expansion

Global Healthcare Opportunities (GHO) Capital, a London-based healthcare investment firm, has recently netted USD 1.1 Billion to advance European healthcare. The company plans to use the proceeds to invest in healthcare companies. Closure of the second round capped at USD 1.1 Billion (Euro 975 Million) is the l...

Find More

Antimicrobial Resistance
Antimicrobial resistance crisis: A global need for antibiotic awareness

Antimicrobial resistance (AMR) is a global threat. As per the UN estimates, the global trends reveal that each year 7,00,000 people die due to drug-resistance. Moreover, around 230,000 people die due to multidrug-resistant tuberculosis. The trends in the US depicted an equally disheartening. A report titled...

Find More

World COPD Day
World COPD Day

World COPD day observed on every 3rd Wednesday of November. This year, on 20th November, we are creating awareness about Chronic Obstructive Pulmonary Disease. COPD is one of the leading causes of mortality and morbidity worldwide. COPD is of two types: Emphysema and Chronic Bronchitis. According to a repor...

Find More